Absci to participate in the bofa securities 2021 tech solutions for drug discovery conference

Vancouver, wash., sept. 13, 2021 (globe newswire) -- absci corporation (nasdaq: absi), the drug and target discovery company harnessing deep learning and synthetic biology to expand the therapeutic potential of proteins, today announced the company will be participating virtually in the upcoming bofa securities 2021 tech solutions for drug discovery conference.
ABSI Ratings Summary
ABSI Quant Ranking